Helicobacter pylori Infection, Gastric Cancer and Gastropanel

1. WITKOUSCA M., SMOLEWSKI P. Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphoma. Mediators of Inflammation. 2013; 2013:523170.Search in Google Scholar

2. CORREA P., PIAZUELO B.M. Helicobacter pylori infection and gastric adenocarcinoma. Gastroenterol Hepatol Rev. 2011; 7(1): 59-64.Search in Google Scholar

3. CORREA P. Human gastric carcinogenesis: a multistep and multifactorial process first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992; 52(24):6735-40.Search in Google Scholar

4. VENERITO M., MALFERTHEINER P., Preneoplastic conditions in the stomach: always a point of no return? Dig Dis 2015; 33:5-10.Search in Google Scholar

5. WONG B.C., LAM S.K., WONG W.M., CHEN J.S., ZHENG T.T., FENG R.E., et al. China gastric cancer study group: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial. JAMA 2004; 291: 187-194.10.1001/jama.291.2.18714722144Search in Google Scholar

6. PATEL S.K., PRATAB C.B., JAIN A.K., GULATI K., NATH G. Diagnosis of Helicobacter pylori: What should be the gold standard? World J Gastroenterol. 2014 Sep 28; 20(36): 12847-59.10.3748/wjg.v20.i36.12847417746725278682Search in Google Scholar

7. http://www.gastropanel.com/ Accessed 28 November 2015.Search in Google Scholar

8. NOAH D., ASSOUMOU M.C., BAGNAKA S.A., NGABA G.P., ALONGE I.E., PALOHEIMO L., NJOYA O., Assessing GastroPanel serum markers as a non-invasive method for the diagnosis of atrophic gastritis and Helicobacter pylori infection. Open Journal of Gastroenterology, 2012; 2:113-118.10.4236/ojgas.2012.23024Search in Google Scholar

9. STORKRUBB T., ARO P., RONKRAINEN J., SIPPONEN P., NYHLIN H., TALLEY NJ., et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol. 2008; 43:1448-55.10.1080/0036552080227302518663663Search in Google Scholar

10. LOMBARDO L., LETO R., MOLINARO G., MIGLIARDI M., RAVARINO N., ROCCAR., TORCHIO B. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med. 2010; 48(9):1327-32.10.1515/cclm.2010.256Search in Google Scholar

11. IIJIMA K., ABE Y., KIKUCHI R., KOIKE T.I., OHARA S., SIPPONEN P., et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol. 2009; 15(7): 853-859.10.3748/wjg.15.853265338619230047Search in Google Scholar

12. LIN J.S. Screening of gastric cancer: Who, when, and how. Clinical Gastroenterology and Hepatology 2014; 12:135-138.10.1016/j.cgh.2013.09.06424107396Search in Google Scholar

13. TERASAWA T., NISHIDA H., KATO K., MIYASHIRO I., YOSHIKAWA T., TAKAKU R., et al. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in eastern Asians: A systematic review and metaanalysis. PLoS One. 2014; 9(10): e109783.10.1371/journal.pone.0109783419695525314140Search in Google Scholar

14. CHOI H.S., LEE S-Y., KIM J.H., SUNG I-K., PARK H.S., SHIM C.S., et al. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm. Journal of Digestive Diseases 2014; 15:293-8.10.1111/1751-2980.1214424602176Search in Google Scholar

15. TU H., SUN L., DONG X., GONG Y., XU O., JING J., et al. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: A longitudinal study. Int J Cancer. 2015; 136(2):425-34.10.1002/ijc.29005435476824895149Search in Google Scholar

16. YEH J.M., HUR C., WARD Z., SCHRAG D., GOLDIE S.J. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: A cost-effectiveness analysis. Gut 2016; 65(4):563-74.10.1136/gutjnl-2014-308588457337025779597Search in Google Scholar

17. KIM B.C., JUNG S.W., KIM J.B., HAN A.R., JANG S., PARK S.H., et al. Serum gastrin levels in different stages of distal gastric carcinogenesis: Is there a role for serum gastrin in tumor growth? Turk J Gastroenterol 2014; 25: 611-8.Search in Google Scholar